| __timestamp | Merck & Co., Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7180000000 | 2242216 |
| Thursday, January 1, 2015 | 6704000000 | 4536244 |
| Friday, January 1, 2016 | 7194000000 | 5184803 |
| Sunday, January 1, 2017 | 9982000000 | 3068742 |
| Monday, January 1, 2018 | 9752000000 | 7178000 |
| Tuesday, January 1, 2019 | 9872000000 | 16267000 |
| Wednesday, January 1, 2020 | 13397000000 | 23191000 |
| Friday, January 1, 2021 | 12245000000 | 21453000 |
| Saturday, January 1, 2022 | 13548000000 | 15265000 |
| Sunday, January 1, 2023 | 30531000000 | 25189000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Merck & Co., Inc. has consistently demonstrated its strategic focus on R&D, with expenditures peaking at an impressive $30.5 billion in 2023. This represents a staggering 325% increase from 2014. In contrast, Soleno Therapeutics, Inc., a smaller player in the industry, has shown a more modest growth in R&D spending, reaching $25.2 million in 2023, a tenfold increase from 2014. This disparity highlights the scale and resources of Merck compared to Soleno, yet both companies underscore the importance of R&D in driving future growth. As the pharmaceutical industry continues to evolve, these investments will likely play a pivotal role in shaping the next wave of medical breakthroughs.
Eli Lilly and Company or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for AbbVie Inc. and Merck & Co., Inc.
R&D Spending Showdown: Merck & Co., Inc. vs GSK plc
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Insmed Incorporated
Analyzing R&D Budgets: Merck & Co., Inc. vs Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
R&D Insights: How Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Dynavax Technologies Corporation
AstraZeneca PLC or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Soleno Therapeutics, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending